sprite-preloader
Anzeige
Mehr »
Dienstag, 27.06.2017 Börsentäglich über 12.000 News von 558 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
11:21OSE Immunotherapeutics halts recruitment in cancer vaccine trial
MoCells held three times as long in 'delayed crosslinking' microgel tech
FrProtein A resin maker teams on continuous and column-free chromatography tech
FrUS FDA rejects Pfizer's Epogen biosimilar citing McPherson site warning
FrEMA committee gives Samsung Bioepis nod for Humira biosimilar Imraldi
FrTakeda prepping to take over EU production of stem cell therapy from 2021
DoImmunoCellular Therapeutics halts brain cancer cell therapy trial due to lack of cash
MiGermany's Merck invests in immune-oncology in Switzerland
MiBrazilian plant to make Humira biosimilar in 'tobacco-based bioreactors'
MiEx-PM David Cameron tells BIO 2017 not to worry about Brexit effect on employees
MiPatient deaths end Seattle Genetics leukaemia Phase III trial
20.06.TxCell hires Lentigen to make vectors used to produce its organ rejection cell therapy
20.06.Single-use in Ireland on the up? GE Healthcare, Thermo Fisher and NIBRT discuss the trend
20.06.Cell Medica buys T cell receptor cancer candidate from UK Catapult
16.06.Wuxi Biologics IPO in Hong Kong brings in $511m
16.06.Sanofi outlines €600m biologics manufacturing investment plan
16.06.Aimmune to make peanut allergy candidate in Florida, US
16.06.The World Bank invests in Indian Biopharma
16.06.US FDA lifts hold on Inovio's cancer vaccine trials after firm answers device questions
14.06.Cell line developer Selexis to be bought by JSR Life Sciences
14.06.Thermo Fisher opens single-use tech testing centre in UK
14.06.Irvine Scientific says it will build a media R&D lab at its Orange County site
14.06.Merck & Co pauses two Ph III Keytruda studies after patient deaths
13.06.Keeping it in the family: Rentschler to offer fill and finish services
13.06.Roche accused of charging too much for Herceptin in South Africa